Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-

This study has been completed.
Information provided by:
GlaxoSmithKline Identifier:
First received: February 24, 2006
Last updated: October 1, 2010
Last verified: October 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2007
  Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):